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Abstract 
Recently portable Raman probes have emerged along with a variety of applications, including 
carbon nanotube (CNT) characterization. Aqueous dispersed CNTs have shown promise for 
biomedical applications such as drug/gene delivery vectors, photo-thermal therapy, and photoa-
coustic imaging. In this study we report the simultaneous detection and irradiation of carbon 
nanotubes in 2D monolayers of cancer cells and in 3D spheroids using a portable Raman probe. A 
portable handheld Raman instrument was utilized for dual purposes: as a CNT detector and as an 
irradiating laser source.  Single-walled  carbon  nanotubes  (SWCNTs)  and  multi-walled  carbon 
nanotubes (MWCNTs) were dispersed aqueously using a lipid-polymer (LP) coating, which formed 
highly stable dispersions both in buffer and cell media. The LP coated SWCNT and MWCNT 
aqueous dispersions were characterized by atomic force microscopy, transmission electron mi-
croscopy, dynamic light scattering, Fourier transform infrared spectroscopy and Raman spec-
troscopy. The cellular uptake of the LP-dispersed SWCNTs and MWCNTs was observed using 
confocal microscopy, and fluorescein isothiocyanate (FITC)-nanotube conjugates were found to 
be internalized by ovarian cancer cells by using Z-stack fluorescence confocal imaging. Biocom-
patibility of SWCNTs and MWCNTs was assessed using a cell viability MTT assay, which showed 
that the nanotube dispersions did not hinder the proliferation of ovarian cancer cells at the dosage 
tested. Ovarian cancer cells treated with SWCNTs and MWCNTs were simultaneously detected 
and irradiated live in 2D layers of cancer cells and in 3D environments using the portable Raman 
probe. An apoptotic terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay 
carried out after laser irradiation confirmed that cell death occurred only in the presence of 
nanotube dispersions. We show for the first time that both SWCNTs and MWCNTs can be 
selectively irradiated and detected in cancer cells using a simple handheld Raman instrument. This 
approach could potentially be used to treat various diseases, including cancer. 
Key  words:  Irradiation,  Raman,  photothermal,  multi-walled  carbon  nanotube  (MWCNT),  sin-
gle-walled carbon nanotube (SWCNT), 3D cell culture. 
INTRODUCTION 
Portable  Raman  probes  have  made  their  way 
into the basic science laboratory through their use to 
detect  and  identify  specific  biological  markers  and 
organic molecules [1-2], but so far their usefulness has 
not  been  tested  for  pre-clinical  theranostic  applica-
tions.  Herein  we  have  studied  the  applicability  of 
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portable  Raman  probes  in  combination  with  nano-
materials for theranostics platforms. With the advent 
of  nanotechnology,  nanomaterials  have  provided  a 
variety  of  options  for  biomedical  applications  [3-5]. 
Carbon  based  nanomaterials,  in  particular,  are  of 
great  interest  internationally,  because  of  their  ap-
plicability  to  biomedicine  [6].  Among  the  carbon 
based nanomaterials, carbon nanotubes (CNTs) have 
excellent  electro-optical  properties,  high  tensile 
strength, and a high surface area-to volume ratio that 
facilitates  surface  functionalization  [7].  CNTs  com-
prise  single-walled  carbon  nanotubes  (SWCNTs), 
double-walled  carbon  nanotubes,  and  multi-walled 
carbon nanotubes (MWCNTs) [8-10]. The above men-
tioned physical properties have enabled tailor-made 
CNT conjugates, such as drug delivery vehicles [11] 
suitable  for  loading  of  various  chemotherapeutic 
drugs (e.g. cisplatin [12], doxorubicin [13], paclitaxel 
[14]), and gene delivery vectors [15-16] (such as siR-
NA) for gene therapy. The toxicity of pristine CNT 
aggregates can be ameliorated by adding a designer 
coat of biocompatible material to make the nanotubes 
highly dispersible in aqueous solution [17-18]. Vari-
ous  oligonucleotide  sequences,  surfactants  and  pol-
ymers can be employed to render CNTs dispersible 
[19-21].  The  most  common  of  these  dispersants  is 
polyethylene  glycol (PEG), an  FDA approved  poly-
mer  used  in  the  pharmaceutical  industry  [22-23]. 
Several  recent  publications  [24-26]  have  found 
PEGylated CNTs to be non-cytotoxic. 
Raman spectroscopy, which determines the vi-
brational,  rotational,  and  other  lower  frequency 
modes of a nanosystem, has been one of the key tools 
for characterizing CNTs [27-28]. Raman spectra give 
unique signature peaks that can identify the CNTs, 
such as the radial breathing mode (RBM) in which all 
the carbon atoms are moving in-phase in the radial 
direction.  Depending  on  the  CNT  diameter,  the  in-
tensity could be strong or weak [29]. The RBM band is 
detected at wave numbers of around 200 – 330 cm-1, 
and the Raman signal strength depends on the CNT 
diameter. In graphitic material, there is another spe-
cific spectral feature, known as the graphene peak or 
G band, which arises from neighboring atoms moving 
in opposite directions along the surface of the tube, as 
well as a second-order related harmonic G’ band [30]. 
The G band peak occurs around 1500 – 1600 cm-1 and 
the G’ is visible around 2600 – 2700 cm-1. The synthesis 
of CNTs using metal catalysts gives rise to structural 
defects producing a dispersive disorder induced peak 
in the Raman spectrum. This defect peak or D band 
occurs at wave numbers around 1300 cm-1 [31]. These 
spectral features enable the identification of different 
types of CNTs. Recently Raman spectroscopy has also 
been  used  to  track  CNTs  both  in vitro  and  in vivo, 
giving rise to a new non-invasive imaging mode to 
track these nanomaterials [24, 32-34].  
In  this  study  we  made  combined  use  of  the 
unique features of portable Raman probes and CNTs 
to  create  a  theranostic  platform  for  ovarian  cancer 
[35]. Ovarian cancer has a very high mortality rate for 
women  around  the  world  [36].  Therapies  based  on 
CNTs  have  shown  promising  results  in  pre-clinical 
experiments by acting as vehicles to deliver drugs and 
genes to cancer tumor cells both in vitro and in vivo 
[37]. CNTs have also been used for pre-clinical pho-
tothermal  therapy  of  breast  cancer  [38-41].  In  this 
study  we report  a  unique  way  of  combining  CNTs 
and  portable  Raman  probes  to  effect  simultaneous 
detection and photothermal ablation of ovarian cancer 
cells  (Supplementary  Material:  Figure  S1).  Tissue 
exhibits a deep penetrability with very low absorption 
of  near-infrared  (NIR)  photons  in  the  wavelength 
range of 700 to 1100 nm [42-43]. In our study we uti-
lized SWCNTs and MWCNTs to kill ovarian cancer 
cells in vitro by selectively detecting and irradiating 
the CNTs both in 2D cell culture and 3D spheroids by 
deploying a portable Raman detector together with a 
handheld Raman laser probe. This study suggests that 
handheld  portable  devices  used  with  specially  de-
signed  theranostic  nanomaterials  could  potentially 
lead to low cost therapies. 
MATERIALS AND METHODS  
Functionalization  of  Carbon  nanotubes. 
SWCNTs  (Aldrich,  MO)  and  MWCNTs  (Helix,  TX) 
were  coated  with  phospholipid  polyethylene  glycol 
amine  (LP)  (1,2-distearoyl-sn-glycero-3- 
phosphoethanolmine-N-[amino(polyethyleneglycol)- 
2000] (ammonium salt) from Avanti Polar Lipids, Inc., 
AL) to render CNTs dispersible in aqueous medium. 
To accomplish this SWCNTs (1 mg) or MWCNTs (1 
mg) were added to an aqueous solution of LP (1 mg 
ml-1) and sonication was carried out with the help of 
an ultra sonicator (Qsonica, CT) for 3 h. This process 
resulted in aqueous dispersed CNTs. To remove any 
uncoated SWCNTs or MWCNTs, the LP coated CNTs 
were centrifuged for 2 h at 10,000 rpm. After the cen-
trifugation the bare uncoated nanotubes settled at the 
bottom of the  vial. The supernatant was  recovered, 
and unreacted LP was removed using a 5K MW cen-
tricon filter and stored for later use.  
FTIR  of  Functionalized  CNTs.  Fourier  trans-
form  infrared  (FTIR)  spectroscopy  of  LP  coated 
SWCNT and MWCNT nanoconjugates, and of pris-
tine SWCNT and MWCNT controls, was done using 
KBr pellets of each. The wave numbers of the trans-
mittance of each sample were recorded using a Per-Theranostics 2011, 1 
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kin-Elmer spectrum GX spectrophotometer. 
Fluorescence  Spectrometry.  Fluorescence spec-
trometer was used to assess the presence of FITC on 
the LP coated SWCNTs or MWCNTs. For this fluo-
rescence  spectra  of  FITC  conjugated  to  LP  coated 
SWCNTs  or  MWCNTs  (with  pristine  SWCNTs  and 
MWCNTs  as  controls)  were  obtained  using  a  Per-
kin-Elmer LS55 fluorescence spectrometer. 
Atomic  Force  Microscope  analysis  of  CNT 
nanoconjugates.  Samples  for  AFM  were  prepared 
and analyzed as described with modifications [44-45]. 
Briefly, biological AFM imaging of the carbon nano-
tube samples was carried out under a range of depo-
sition conditions in fluid, rinsed with deionized water 
and dried under a gentle flow of N2 or Ar gas, using a 
gentle tapping-mode on a PicoForce Multimode AFM 
(Bruker, CA) consisting of a Nanoscope® V controller, 
a  type  E  scanner  head,  and  a  sharpened  TESP-SS 
(Bruker, CA),  OMCL (Bruker, CA), or similar AFM 
cantilever.  For  either  SWCNT  or  MWCNT  sample 
visualization,  suitable  surface  attachment  of  the  re-
spective sample was achieved readily by 5 min incu-
bation  of  20  μL  of  the  fluid  suspension  on  fresh-
ly-peeled mica disks of 12 mm diameters. The excess 
fluid was blown away by an inert gas gust, or blotted 
with filter paper, followed by two rinses each with 30 
μL of deionized water to remove salt deposits and by 
a complete drying of the sample surface under gentler 
gas  flow.  The  sample  was  then  sealed  into  the  in-
strument  compartment  (dehumidified  by  Drierite® 
particles)  and  imaged  via  standard  optimizations. 
AFM images were evaluated within the Nanoscope 
software (version 7.2, Bruker), and exported to Image 
J (version 1.4x, NIH, Bethesda, MD) for further anal-
yses and display. 
Zeta Potential. To find the surface charge of LP 
coated SWCNTs and MWCNTs, zeta potential analy-
sis  was  carried-out  using  a  Zetasizer  Nano  series 
(Zen3600) from Malvern with Zetasizer software 6.0 
as the interface. 
Raman  analysis  of  CNT  nanoconjugates.  Ra-
man characterization was used for the analysis of the 
functionalized LP coated SWCNT and MWCNT sam-
ples for specific signature peaks along with controls 
consisting of pristine SWCNTs and MWCNTs. Raman 
characterization  of  aqueous  dispersed  CNTs  was 
done  by  using  characteristic  SWCNT/MWCNT  Ra-
man signature peaks (G and D bands). Raman spectra 
were recorded on an iRaman 785 (B&W Tek, Inc, DE) 
spectrometer  equipped  with  a  microscope  attach-
ment, and laser spot size was focused to 1 μm diame-
ter (×100 objective), with a power output of 35 mW. 
The excitation source was an argon ion laser, 785 nm. 
2D  and  3D  cell  culture.  For  2D  cell  culture, 
OVCAR8 ovarian cancer cells were cultured in RPMI 
(Invitrogen) supplemented with 10% fetal bovine se-
rum (FBS) at 37°C in 95% air/5% CO2. Freshly plated 
cells  were  grown  overnight,  to  50-70%  confluency 
prior to incubation for 3 hrs with 200 μL RPMI con-
taining either LP coated SWCNTs or MWCNTs, and 
after 3 washes with PBS the treated cells were incu-
bated  further  in  fresh  RPMI  containing  serum  and 
carefully monitored microscopically (Axiovert 200m; 
Carl Zeiss). For 3D cell cultures, OVCAR8 cells were 
trypsinized,  collected,  mixed  with  matrigel,  and 
plated in 8 well chambered cultured slides, which had 
been previously coated with a thin layer of matrigel. 
The matrigel mixed cells were observed for the sphe-
roid formation. 
Cell  proliferation  (MTT)  assay.  Cells  were 
grown  to  50-70%  confluency  overnight  in  96  well 
plates. Next, the media was aspirated and  the cells 
incubated  with  fresh  media  containing  either  LP 
coated SWCNTs or MWCNTs at various concentra-
tions along with control cells for 48 h. Post treatment 
the cells were washed 2 times in PBS, and then incu-
bated for an additional 24 h in fresh media. MTT was 
assessed using a CellTiter 96 AQ One Solution Cell 
Proliferation Assay kit (Promega, WI), and measured 
optically at 570 nm.  
TUNEL assay. An APO-BrdU TUNEL (Terminal 
transferase dUTP nick end labeling) assay kit (Invi-
trogen,  CA)  was  used  to  detect  cells  undergoing 
apoptosis.  Briefly,  cells  were  grown  onto  8  well 
chambered cell culture slides until 50-70% confluent, 
followed  by  treatment  with  either  SWCNTs  or 
MWCNTs. Control cells were grown in the absence of 
CNTs. After treatment, the cells were washed in PBS 
(3x for 2 min each) and incubated in fresh media for 1 
h. Next, cells were fixed in 3.5 % PBS-formaldehyde 
for 15 min at RT, rinsed in PBS (3x) and permeabilized 
in 0.5 % PBS-Tween 20 for 5 min at RT followed by 
DNA end-labeling for 1 h at 37 °C. Then, the labeled 
cells were washed, and incubated further with 95 μL 
antibody  staining  solution  (AlexaFluor 
488-conjugated  anti-BrdU)  for  30  min  at  37  °C,  fol-
lowed by additional washes (3x). Fluorescence image 
acquisitions were performed with an Axioplan 2 (Carl 
Zeiss). 
Confocal microscopy. OVCAR8 ovarian cancer 
cells were grown 50-70% confluent on 8-well cham-
bered LabTek II coverglass, treated with either FITC 
or Qdot conjugated LP coated SWCNTs or MWCNTs, 
as described above and, incubated for 3 h. Cells were 
next washed with PBS (3x) and resuspended in fresh 
media.  Live  cell  imaging  was  performed  using  an 
inverted  Zeiss  LSM  700  confocal  microscope 
equipped with a CO2 module, heating unit and heat-Theranostics 2011, 1 
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ing  plate,  using  a  40x/0.75  M27  EC  Plan-Neofluar 
objective. Imaging was carried out at 37°C in 5% CO2 
with cells plated in LabTek II coverglass (Nalge Nunc 
International,  NY).  Images  were  acquired  and  pro-
cessed with the Zeiss Zen 2009 image software. The 
fluorescence micrographs shown are representative of 
at least three independent experiments. Average flu-
orescence  intensity  was  quantified  using  Zen  2009 
software. 
Transmission  electron  microscope  imaging  of 
SWCNTs/MWCNTs.  A  specimen  of  LP-coated 
SWCNTs  or  MWCNTs  for  TEM  imaging  was  pre-
pared by depositing a 3 μL droplet from the aqueous 
solution onto a Quantifoil grid and letting it dry in air. 
After adsorption for 3 min, the excess solution was 
blotted  with  filter  paper,  washed  with  a  few  3-μl 
droplets of de-ionized water in order to remove any 
dirt,  and  left  to  dry.  Transmission  electron  micro-
graphs were recorded by means of a Tecnai TF30 TEM 
(FEI, Hillsboro, OR) equipped with a Gatan Ultrascan 
1000 CCD camera (Gatan, Pleasaton, CA). 
RESULTS AND DISCUSSION 
Preparation  and  characterization  of  CNT 
nanoconjugates. To enable CNTs to be used for pho-
tothermal  therapy  it  is  essential  to  preserve  their 
structural integrity and, thus, the spectral response of 
the nanomaterial. The SWCNTs and MWCNTs were 
dispersed  in  a  phospholipid-polyethyelene  glycol 
(LP)  containing  a  terminal  amine  functional  group. 
LP-coated  CNTs  obtained  by  sonication  in  aqueous 
medium  were  a  highly  water  dispersible  CNT  sus-
pension without any strong visual aggregation. The 
CNT suspension was stable  for at least two weeks, 
which can be attributed to the strong adsorption of the 
lipid moieties to the surface of the CNTs. The CNT 
nanoconjugates  were  characterized  by  atomic  force 
microscope  (AFM,  Figure  1A&B)  and  transmission 
electron microscope (TEM, Figure 1C&D) for length 
and diameter distribution. AFM data showed that the 
SWCNTs were 50 – 500 nm in length with a few over 
1000  nm  and  0.5  –  1.5  nm  in  diameter,  whereas 
MWCNTs were somewhat shorter in the similar range 
of the length but about 10 – 30 nm in diameter indi-
cating a higher degree of CNT dispersion apart from a 
few smaller CNT bundles. Similar data resulted from 
the TEM analysis with SWCNTs having diameters of 
0.5 – 1.5 nm and MWCNTs having diameters of 10 – 
30 nm, supporting the fact that the LP coating yielded 
mostly  debundled  individual  SWCNTs  and 
MWCNTs. To make sure that the intrinsic electronic 
and  spectroscopic  properties  of  SWCNTs  and 
MWCNTs were not significantly affected by the LP 
coating, a Raman spectroscopic analysis was carried 
out  (Figure  1E&F).  Raman  spectra  of  LP  coated 
SWCNTs  and  MWCNTs  were  recorded  using  a 
handheld portable iRaman 785 (B&W Tek, Inc, DE) 
laser  probe  (Supplementary  Material:  Figure  S2). 
SWCNTs showed well resolved G and G’ band peaks 
at 1590 cm-1 and ~2600 cm-1, respectively, and an RBM 
band was visible at 390 cm-1 together with a D band at 
~1420 cm-1. The Raman spectra clearly show that the 
fundamental signature peaks of SWNCTs were pre-
served after the coating. MWCNTs also showed a G 
band at  ~1590  cm-1 and  G’  band at  ~2600  cm-1,  alt-
hough  it  should  be  noted  that  the  Raman  intensity 
was weak compared to that from SWCNTs at 785-nm 
laser excitation, as has been reported previously [46]. 
To  evaluate  the  CNT  nanoconjugates  further 
with  regard  to  their  surface  charges  and  functional 
groups, zeta potential analysis and Fourier transform 
infrared (FTIR) spectroscopy were carried out. FTIR 
spectra indicated the presence of the LP coat (Figure 
2A). LP coated SWCNTs and MWCNTs were further 
conjugated with a fluorescent dye, fluorescein isothi-
ocyanate  (FITC),  and  characterized  by  spectrofluo-
rometry (Figure 2B). The spectrum showed a peak at 
521 nm, which is the emission maximum for the un-
conjugated  control  FITC;  the  dye-labeled  SWCNTs 
and  MWCNTs  also  showed  the  peak  at  521  nm, 
whereas control SWCNTs and MWCNTs lacking the 
dye did not show any peak in this spectral region. The 
data  clearly  showed  that  CNTs  were  labeled  with 
FITC,  which  was  later  used  to  observe  the  cellular 
uptake of the CNT nanoconjuagtes. The zeta potential 
analysis gave us an indication of the extent of positive 
charge on the surface of the SWCNTs (18.5 mV) and 
MWCNTs  (5  mV)  (Figure  2C).  The  data  also  point 
towards a 2-fold higher coating of LP on the SWCNTs 
compared to that on the MWCNTs, suggesting that a 
higher molecular weight LP coating could yield still 
better CNT dispersions, especially for MWCNTs. 
Cellular uptake  and cell proliferation studies 
of  LP  coated  SWCNTs  and  MWCNTs  in  ovarian 
cancer cells. Most previous studies involving CNTs as 
delivery vehicles have utilized targeting moieties that 
could help take up nanoconjugates into cells. How-
ever, in the present studies we kept the nanoformula-
tion  in  its  simplest  form  and  used  dispersed, 
LP-coated CNT nanoconjugates directly to treat the 
cancer cells. We first tested cellular uptake of the CNT 
nanoconjugates  by  using  confocal  fluorescence  mi-
croscopy. OVCAR8 [47] ovarian cancer cells were first 
cultured in 8-well chambered culture slides, and after 
reaching  70%  cell  confluency  the  cells  were  treated 
with  either  LP-coated  SWCNTs  or  LP-coated 
MWCNTs, both of which had been labeled with FITC 
for an hour, after which the cells were washed twice Theranostics 2011, 1 
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with PBS. Fresh medium was added after the wash-
ing,  and  confocal  Z-stack  imaging  was  performed 
(Figure  3A&B).  The  Z-stack  confocal  fluorescence 
imaging clearly showed cellular uptake of SWCNTs 
and  MWCNTs  as  evidenced  by  the  green  emission 
from the FITC dye at a wavelength of 520 nm. This 
result indicated that SWCNTs and MWCNTs could 
diffuse through the cell membrane and that the posi-
tive charge on the CNT surface mediated their cellular 
uptake,  as  had  been  observed  in  a  previous  report 
[48]. 
Once the cellular uptake of LP-coated SWCNTs 
and  MWCNTs  was  determined,  the  effect  of  CNT 
nanoconjugates on the proliferation of OVCAR8 cells 
was tested. Cells were cultured in 96-well plates in 
triplicates,  and  when  the  cells  were  70%  confluent, 
they were treated with a range of doses of LP-coated 
aqueous  dispersed SWCNTs  or  MWCNTs. After 48 
hrs of treatment the cells were analyzed by an MTT 
cell proliferation assay to compare the proliferation of 
the cells alone (as a control) to the proliferation of cells 
treated with various doses of SWCNTs and MWCNTs 
ranging from 2 to 100 µg/mL-1. As shown in the plot 
in Figure 3C, the LP-coated SWCNTs and MWCNTs 
did not hinder proliferation of the OVCAR8 cells at 
the tested dosages. Higher doses of CNTs were found 
to be toxic (data not shown). To investigate irradiation 
of the OVACAR ovarian cancer cells we employed the 
highest  dosage  of  the  SWCNTs  and  MWCNTs  that 
did not hinder the cell proliferation. 
 
 
 
Figure 1. AFM, TEM and Raman analysis of SWCNTs/MWCNTs dispersed in PL-PEG-NH2. AFM imaging of 
SWCNT (A) and MWCNT (B) samples on freshly peeled Mica surface. The 300 nm XY scale bar applies to both A and B, and 
the gray scales for topological height are 0 - 7 nm for A and 0 - 100 nm for B, respectively. The tube height in the SWCNT 
sample ranges from 0.7 to 1.5 nm. In contrast, the cross section heights in the MWCNT sample range from 10 to 30 nm. 
Whereas some SWCNTs are longer than 1 μm in length, MWCNTs are somewhat shorter. (C, D) TEM images of the 
SWCNTs/MWCNTs show well dispersed nanotubes. (E, F) Raman spectroscopic analysis of the LP dispersed SWCNTs and 
MWCNTs at a laser excitation of 785 nm. Raman spectra of LP dispersed SWCNTs (left) show the signature G band at 
~1590 cm
-1
 and G’ band at ~ 2600 cm
-1
 which are used to detect the nanotubes in the cells. Raman spectra of LP dispersed 
MWCNTs also show the respective G and G’ peaks (right).  Theranostics 2011, 1 
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Figure 2. FTIR and fluorescence spectroscopic characterization and surface charge analysis of PL-PEG-NH2 
dispersed SWCNTs/MWCNTs. FTIR spectra on the left show the spectral changes occurring to pristine SWCNTs (Ab) 
and MWCNTs (Ad) after treatment with phospholipid-PEG (LP) dispersant. SWCNTs (Aa) and MWCNTs (Ac) show the 
amine peaks (C=O, red and N-H, blue) at around ~1500 – 1700 cm
-1. Fluorescence spectra of LP dispersed SWCNTs (Ba) 
and MWCNTs (Bb) do not show any fluorescence while FITC labeled SWCNTs (Bc) and MWCNTs (Bd) fluoresce at 520 
nm along with control FTIC alone (Be). Zeta potential analysis shows a positive surface on LP dispersed nanotubes (C). 
 
Figure 3 Cellular uptake and biocompatibility of 
SWCNTs and MWCNTs in vitro. OVCAR8 ovar-
ian  cancer  cells  treated  with  SWCNTs  (A)  and 
MWCNTs (B) dispersed in PL-PEG-NH2 and labeled 
with  FITC  were  imaged using  confocal  fluorescence 
microscope. The green fluorescence clearly shows that 
the carbon nanotubes were taken up by the cancer cells 
2 h post treatment. (C) OVCAR8 ovarian cancer cells 
were treated with SWCNT s/ MWCNTs dispersed in 
PL-PEG-NH2  to  test  cellular  toxicity  and  evaluated 
using cell proliferation colorimetric MTT assay. 
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Live cellular detection of CNTs nanoconjugates 
using a portable Raman probe. For live cellular de-
tection of SWCNTs and MWCNTs, a handheld porta-
ble  iRaman  instrument  with  a  785-nm  laser  source 
was  utilized.  Cultured  OVCAR8  cells  were  first 
probed with a 785-nm laser using the iRaman laser 
probe, and the resulting spectrum did not show any 
peaks  attributable  to  CNTs  (Figure  4A).  Next  the 
OVCAR8  cells  were  treated  with  either  LP-coated 
SWCNTs or LP-coated MWCNTs and the laser irra-
diation was applied to the ovarian cancer cells. Dis-
tinct  carbon  nanotube  peaks  were  observed  in  the 
Raman spectra (Figure 4B&C). The CNT Raman sig-
nals tended to decrease and disappear over time at 
certain spots in the culture well, whereas signals were 
retained for longer periods of time in other regions of 
the  culture  well.  Possible  explanations  for  this  be-
havior are that the cells might be in dynamic motion 
within the culture well, or that SWCNTs/MWCNTs 
might be internalized by the cancer cells, thus giving 
more  continuous  signals  than  the  signals  from  the 
non-internalized  nanoparticles.  To  confirm  this  be-
havior we washed the cells with buffer, resuspended 
them in media, and probed them under the 785-nm 
laser light to see if we could obtain any CNT Raman 
signal. Indeed we observed Raman signals that were 
of lower intensity. Raman signals were also observed 
in  the  washing  solution  suggesting  that  unbound 
nanotubes that did not internalize were washed away. 
Clear MWCNT Raman peaks were hard to detect in 
vitro with the 785-nm laser light, because of the very 
low  signal  intensity.  The  observation  that  Raman 
signals  were  only  detected  when  the  laser  probe 
traversed CNTs, and never in the absence of CNTs, 
showed the advantage of using a portable handheld 
device in combination with nanomaterials.  
 
 
 
Figure 4. Raman spectra of SWCNT-PL-PEG-NH2 and MWCNT-PL-PEG-NH2 in 2D cell culture in vitro. 
OVCAR8 ovarian cancer cells treated with LP dispersed SWCNTs and MWCNTs for 3 hrs and washed were subjected to 
Raman analysis to detect the presence of nanotubes using a handheld portable iRaman spectrometer with a 785 nm laser 
source. (A) Untreated cells, serving as controls, did not show any characteristic CNT peaks. The SWCNTs (B) and 
MWCNTs (C) treated cells indeed showed the characteristic G peaks. Theranostics 2011, 1 
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Live cellular simultaneous detection and irra-
diation  of  CNT  nanoconjugates.  For  simultaneous 
detection and irradiation of the CNTs in vitro, a ther-
mal  profile  of  the  nanotubes  was  first  carried  out 
(Supplementary  Material:  Figure  S3).  To  achieve 
this, a k-type thermocouple was used to measure the 
temperature levels of the irradiated CNTs at different 
time intervals. SWCNTs/MWCNTs were introduced 
into the cell culture wells in the absence of cells. Ra-
man  laser  light  was  shone  onto  the  CNTs  continu-
ously  using  the  785-nm  portable  handheld  iRaman 
laser  probe.  The  temperature  of  the  LP-coated 
SWCNTs/MWCNTs  rose  sharply  to  around  43  °C 
after 3 to 15 min, depending on the concentration of 
CNTs. We also found that the rise in temperature of 
MWCNTs  was  faster  than  that  of  SWCNTs.  Cells 
treated  with MWCNTs  at  the  highest concentration 
that didn’t show cytotoxicity in the cell viability assay 
reached a temperature of 32 °C after just 100 seconds 
of NIR irradiation. This compared to the 180 seconds 
that cells treated with SWCNTs took to reach the same 
temperature. OVCAR8 cells were treated for 3 hrs at 
this  optimal  dosage  with  LP-coated 
SWCNTs/MWCNTs and were then subjected to NIR 
laser  irradiation  in  regions  where  the  CNTs  were 
traced with the 785-nm iRaman laser probe. Change in 
temperature of the cell media was recorded using the 
thermocouple which reached around 43 oC. After NIR 
laser irradiation the cells were fixed and stained for 
analysis using a TUNEL assay. Cells irradiated in the 
absence of CNTs showed neither the CNT peaks nor 
signs of apoptosis (Figure 5A&B), whereas LP-coated 
SWCNTs and MWCNTs both showed apoptosis in-
duced  by  laser  irradiation  of  the  OVCAR8  ovarian 
cancer  cells  (Figure  5C-F).  Interestingly,  not  only 
could we detect the CNTs in vitro, but we could also 
kill  the cancer cells by prolonged irradiation of the 
SWCNTs/MWCNTs.  TUNNEL  staining  of  cells 
treated with CNTs in absence of laser did not show 
any  signs  of  apoptosis  (Supplementary  Material: 
Figure S4). These results show promise for the use of 
portable  handheld  devices  in  combination  with  na-
nomaterials  for  detecting,  thermally  irradiating  and 
killing  cancer  cells  with  minimal  dosages  of  nano-
materials.  
 
 
 
Figure  5.  Raman  spectra  and  TUNEL 
staining  of  SWCNT-PL-PEG-NH2  and 
MWCNT-PL-PEG-NH2  in  2D  cell  cul-
ture in vitro. OVCAR8 ovarian cancer cells 
treated  with  LP  dispersed  SWCNTs  and 
MWCNTs for 3 hrs were subjected to Raman 
analysis to detect the presence of nanotubes 
using a handheld portable iRaman spectrom-
eter  with  a  785  nm  laser  source.  The  un-
treated  control  well  (A)  did not  show  any 
nanotube  peak  while  SWCNTs  (C)  and 
MWCNTs  (E)  treated  cells  indeed  showed 
the characteristic G peaks. TUNEL staining 
was done on irradiated cells in the presence 
and  absence  of  CNTs  to  detect  apoptosis. 
Control  cells  (B)  did  not  show  any  green 
fluorescence indicating that the irradiation did 
not prompt apoptosis. While cells irradiated 
in  the  presence  of  both 
SWCNT-PL-PEG-NH2  (D)  and 
MWCNT-PL-PEG-NH2  (F)  showed  green 
fluorescence  indicating  the  presence  of 
apoptosis.  
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Simultaneous detection and irradiation of CNT 
nanoconjugates in a 3D environment. With the en-
couraging results from 2D cell cultures next we con-
sidered  whether  similar  results  could  be  obtained 
from 3D cell cultures, which would provide a more 
realistic model for the in vivo environment. OVCAR8 
ovarian cancer cells were cultured in standard mat-
rigel  where  the  cancer  cells  grew  in  a 
three-dimensional geometry (Figure 6). 3D uptake of 
QSA580 (Ocean Nano Tech, LLC, AK)-labeled CNTs 
was assessed using Z-stack confocal imaging (Figure 
6A).  OVACAR8  cell  spheroids  were  treated  with 
LP-coated SWCNTs/MWCNTs for 3 hrs and then the 
spheroids were irradiated using the iRaman 785-nm 
laser  probe.  A  strong  SWCNT  signal  was  detected, 
whereas the MWCNT signal was very weak and dif-
ficult  to  detect.  Continuous  irradiation  showed  a 
temperature rise that was detectable by a thermocou-
ple.  After irradiation  cells  were stained  for  TUNEL 
assay. Control spheroids that were irradiated in the 
absence  of  CNTs  did  not  show  green  fluorescence. 
NIR laser on its own did not harm the cancer cells 
(Figure  7A&B).  Cellular  TUNEL  staining  indicated 
which cells were undergoing apoptosis (Figure 7C-F) 
following  treatment  with  LP-coated  SWCNT  or 
MWCNTs and laser light. The intense signal of the 
SWCNTs could be due to more nanotubes being ac-
cumulated in the three-dimensional cellular structure 
than  in  the  single  layers  of  cells  in  the  2D  culture. 
Although MWCNTs are also effective at killing cancer 
cells  these  nanoparticles  are  difficult  to  track  with 
Raman  probes.  These  results  strongly  suggest  the 
advantage of using SWCNTs for simultaneous detec-
tion and killing of cancer cells using portable Raman 
probes. Addition of a targeting ligand onto the nano-
tubes would increase the target specificity. 
 
Figure 6. Raman probing of SWCNT-PL-PEG-NH2 and MWCNT-PL-PEG-NH2 in 3D spheroids. OVCAR8 
ovarian cancer cell spheroids (A, Z-stack image) treated with LP dispersed SWCNTs (B, D) and MWCNTs (C, E) labeled 
with Qdots (red), for 3 h and washed were subjected to Raman analysis to detect the presence of nanotubes using a 
handheld portable iRaman spectrometer with a 785 nm laser source. The SWCNTs (F) and MWCNTs (G) treated cells 
indeed showed the characteristic G peaks. Theranostics 2011, 1 
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Figure 7. Raman spectra and TUNEL staining of SWCNT-PL-PEG-NH2 and MWCNT-PL-PEG-NH2 in 3D 
spheroids. The untreated control well (A) did not show any nanotube peaks, while SWCNTs (C) and MWCNTs (E) 
treated cells indeed showed the characteristic G peaks. TUNEL staining was done on irradiated cells in the presence and 
absence of CNTs to detect apoptosis. Control cells (B) did not show any green fluorescence, indicating that the irradiation 
did  not  prompt  apoptosis.  While  cells  irradiated  in  the  presence  of  both  SWCNT-PL-PEG-NH2  (D)  and 
MWCNT-PL-PEG-NH2 (F) showed green fluorescence indicating apoptosis.  
 
CONCLUSION  
Carbon based nanomaterials show a strong po-
tential for biomedical applications, and carbon nano-
tubes are effective as drug and gene delivery vehicles. 
Nanotubes themselves can be used as ―heat bombs‖ to 
kill cancer cells. Here, we have shown how the unique 
Raman properties of SWCNTs/MWCNTs in combi-
nation with a portable handheld device can be em-
ployed to kill cancer cells simultaneously by means of 
thermal irradiation. SWCNTs/MWCNTs can diffuse 
into  and  be  taken  up  by  cancer  cells  grown  in  a 
three-dimensional environment. Our results indicate 
that MWCNTs have a higher thermal generation ca-
pacity  but  are  harder  to  detect  because  of  the  low 
Raman signal intensity at a wavelength of 785 nm. We 
have found that the SWCNTs provide a more suitable 
platform, because —in addition to being able to raise 
cellular temperatures—they can be detected easily. 
Supplementary Material 
Figure S1-S4. http://www.thno.org/v01p0310s1.pdf 
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